Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
Mini Reviews in Medicinal Chemistry
|
June 25, 2005
Structure-activity relationships for the design of small-molecule inhibitors
Adriano D Andricopulo, Carlos A Montanari
Journal of Computer-Aided Molecular Design
|
January 12, 2013
Inflation of correlation in the pursuit of drug-likeness
Peter W Kenny, Carlos A Montanari
Chemmedchem
|
January 24, 2023
Investigating the Lack of Translation from Cruzain Inhibition to Trypanosoma cruzi Activity with Machine Learning and Chemical Space Analyses
Rafael F Lameiro, Carlos A Montanari
European Journal of Medicinal Chemistry
|
October 24, 2007
In silico screening of HIV-1 non-nucleoside reverse transcriptase and protease inhibitors
Andrei Leitão, Adriano D Andricopulo, Carlos A Montanari
Journal of Computer-Aided Molecular Design
|
June 6, 2014
Ligand efficiency metrics considered harmful
Peter W Kenny, Andrei Leitão, Carlos A Montanari
Bioorganic & Medicinal Chemistry
|
November 13, 2007
2D QSAR and similarity studies on cruzain inhibitors aimed at improving selectivity over cathepsin L
Renato F Freitas, Tudor I Oprea, Carlos A Montanari
Bioorganic & Medicinal Chemistry
|
September 18, 2007
Hologram QSAR model for the prediction of human oral bioavailability
Tiago L Moda, Carlos A Montanari, Adriano D Andricopulo
Journal of Computer-Aided Molecular Design
|
June 6, 2013
ClogP(alk): a method for predicting alkane/water partition coefficient
Peter W Kenny, Carlos A Montanari, Igor M Prokopczyk
Expert Opinion on Drug Discovery
|
July 25, 2012
The GRID/CPCA approach in drug discovery
Josmar R Rocha, Renato F Freitas, Carlos A Montanari
Steroids
|
February 17, 2006
Three-dimensional models of non-steroidal ligands: a comparative molecular field analysis
Irwin R A Menezes, Andrei Leitão, Carlos A Montanari
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
Mini Reviews in Medicinal Chemistry
|
June 25, 2005
Structure-activity relationships for the design of small-molecule inhibitors
Adriano D Andricopulo, Carlos A Montanari
Journal of Computer-Aided Molecular Design
|
January 12, 2013
Inflation of correlation in the pursuit of drug-likeness
Peter W Kenny, Carlos A Montanari
Chemmedchem
|
January 24, 2023
Investigating the Lack of Translation from Cruzain Inhibition to Trypanosoma cruzi Activity with Machine Learning and Chemical Space Analyses
Rafael F Lameiro, Carlos A Montanari
European Journal of Medicinal Chemistry
|
October 24, 2007
In silico screening of HIV-1 non-nucleoside reverse transcriptase and protease inhibitors
Andrei Leitão, Adriano D Andricopulo, Carlos A Montanari
Journal of Computer-Aided Molecular Design
|
June 6, 2014
Ligand efficiency metrics considered harmful
Peter W Kenny, Andrei Leitão, Carlos A Montanari
Bioorganic & Medicinal Chemistry
|
November 13, 2007
2D QSAR and similarity studies on cruzain inhibitors aimed at improving selectivity over cathepsin L
Renato F Freitas, Tudor I Oprea, Carlos A Montanari
Bioorganic & Medicinal Chemistry
|
September 18, 2007
Hologram QSAR model for the prediction of human oral bioavailability
Tiago L Moda, Carlos A Montanari, Adriano D Andricopulo
Journal of Computer-Aided Molecular Design
|
June 6, 2013
ClogP(alk): a method for predicting alkane/water partition coefficient
Peter W Kenny, Carlos A Montanari, Igor M Prokopczyk
Expert Opinion on Drug Discovery
|
July 25, 2012
The GRID/CPCA approach in drug discovery
Josmar R Rocha, Renato F Freitas, Carlos A Montanari
Steroids
|
February 17, 2006
Three-dimensional models of non-steroidal ligands: a comparative molecular field analysis
Irwin R A Menezes, Andrei Leitão, Carlos A Montanari
Page
of 7